Evaluation of the extended efficacy of the Dengvaxia vaccine against symptomatic and subclinical dengue infection-Reference-Cited by-同舟云学术

Evaluation of the extended efficacy of the Dengvaxia vaccine against symptomatic and subclinical dengue infection

Published:2021-06-24 Issue:8 Volume:27 Page:1395-1400
ISSN:1078-8956
Container-title:Nature Medicine
language:en
Short-container-title:Nat Med

Author:

Salje Henrik^ORCID,Alera Maria Theresa,Chua Mary Noreen,Hunsawong Taweewun,Ellison Damon,Srikiatkhachorn Anon,Jarman Richard G.^ORCID,Gromowski Gregory D.,Rodriguez-Barraquer Isabel,Cauchemez Simon^ORCID,Cummings Derek A. T.^ORCID,Macareo Louis,Yoon In-Kyu,Fernandez Stefan,Rothman Alan L.

Publisher

Springer Science and Business Media LLC

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Link

https://www.nature.com/articles/s41591-021-01392-9.pdf

Reference17 articles.

1. Stanaway, J. D. et al. The global burden of dengue: an analysis from the Global Burden of Disease Study 2013. Lancet Infect. Dis. 16, 712–723 (2016).

2. Hadinegoro, S. R. et al. Efficacy and long-term safety of a dengue vaccine in regions of endemic disease. N. Engl. J. Med. 373, 1195–1206 (2015).

3. Wilder-Smith, A. et al. Deliberations of the Strategic Advisory Group of Experts on Immunization on the use of CYD-TDV dengue vaccine. Lancet Infect. Dis. 19, e31–e38 (2019).

4. Moi, M. L., Takasaki, T. & Kurane, I. Human antibody response to dengue virus: implications for dengue vaccine design. Trop. Med. Health 44, 1 (2016).

5. Salje, H. et al. Reconstruction of antibody dynamics and infection histories to evaluate dengue risk. Nature 557, 719–723 (2018).

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dengue vaccine endgame: why has the global response to exponential demand in the tropics been so slow?;Frontiers in Tropical Diseases;2024-09-09

2. Trends and insights in dengue virus research globally: a bibliometric analysis (1995–2023);Journal of Translational Medicine;2024-09-03

3. Cordycepin exhibits both antiviral and anti-inflammatory effects against dengue virus infection;iScience;2024-09

4. Efficacy, public health impact and optimal use of the Takeda dengue vaccine;2024-08-11

5. B cell receptor dependent enhancement of dengue virus infection;2024-06-30